TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Exclusion Criteria

• •1. The subject is known to be allergic to the investigational drug or its excipients;
• •2. The subject has a disease or injury that interferes with functional assessment or threatens life, or is accompanied by a serious irreversible disease of the heart, lung, liver, or brain, or is accompanied by a failure of different organs (for patients with respiratory failure, only patients diagnosed as type I or type II respiratory failure are excluded);
• •3. The subject has a major mental illness or cognitive dysfunction;
• •4. Patients with a history of secondary or above surgery within one month before the screening period;
• •5. The subjects participated in other clinical studies within 1 month;
• •6. The subjects are pregnant or lactating women;
• •7. Poor compliance or other researchers believe that there are any circumstances that are not suitable for inclusion.
• •\-